Drafting our elevator pitch for explaining Alagille syndrome
Having a newborn baby is an exciting time. If you need to go out in public, there is no hiding a newborn. They’re like a…
Having a newborn baby is an exciting time. If you need to go out in public, there is no hiding a newborn. They’re like a…
A possible therapeutic target for fatty liver disease (FLD) has been identified by researchers studying the natural defense mechanisms of certain cave-dwelling fish. While…
The Kasai surgical procedure can significantly delay liver transplant and reduce liver disease severity before transplant in children with biliary atresia, according to…
The U.S. Food and Drug Administration (FDA) has approved Rezdiffra (resmetirom) for the treatment of people with noncirrhotic nonalcoholic steatohepatitis (NASH) — a severe type…
Atea Pharmaceuticals’ once-daily oral antiviral treatment for hepatitis C virus (HCV) — a combination of bemnifosbuvir and ruzasvir — successfully cleared HCV within…
The U.S. Food and Drug Administration (FDA) has approved Mirum Pharmaceuticals’ Livmarli (maralixibat) to reduce pruritus, or itching, in adults and children, 5 years…
LISCure Biosciences will launch a Phase 2 trial in the United States to evaluate the safety and effectiveness of LB-P8, its live bacterium candidate…
Treatment with an oral medication called sodium 4-phenylbutyrate — approved to treat diseases in which the body fails to remove a waste called ammonia…
Drinking a small amount of alcohol each day did not raise the mortality risk among people in the early stages of steatotic liver disease…
Before my son Finley was born in 2021, I had never heard of Alagille syndrome. For that matter, I had only surface-level knowledge of…